SBI Securities »

Adial Pharmaceuticals shares owned by SBI Securities

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by SBI Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $83 47 1.79

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Vanguard Total World Stock ETF Etf (VT)
Tesla Motors (TSLA)
Alphabet Inc Class A cs (GOOGL)
Vanguard High Dividend Yield ETF Etf (VYM)
Amazon (AMZN)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
ST SPDR Portfolio S&P500HighDividend ETF Etf (SPYD)
SPDR Gold MiniShares Trust Etf (GLDM)
Alphabet Inc Class C cs (GOOG)

View all positions for SBI Securities

Top funds holding Adial Pharmaceuticals

Geode Capital Management
Vanguard Fiduciary Trust
Manchester Capital Management
BlackRock
UBS Group
Vanguard Capital Management
Morgan Stanley
SBI Securities
Caitong International Asset Management
Wells Fargo & Company
Northwestern Mutual Wealth Management Company
Harbour Investments
Abound Wealth Management

View all funds holding Adial Pharmaceuticals